CIDRAP newsletters options
According to the World Health Organization's (WHO) online dashboard, 10 new cases of Ebola have been confirmed in the Democratic Republic of the Congo (DRC), raising the outbreak total to 2,852, and 380 suspected cases are still under investigation.
Fatalities have passed the 1,900 mark, to stand at 1,905, after seven new deaths from the virus were confirmed today.
An analysis of data from routine antibiotic susceptibility testing in 30 European countries shows a strong correlation between the rates of intrinsically antibiotic-resistant bacterial species and the rates of acquired resistance in gram-negative bacterial species, a team of European researchers reported today in Eurosurveillance.
The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.
Burundi yesterday began vaccinating front-line workers against Ebola, part of efforts to prepare for possible Ebola cases, the World Health Organization (WHO) said today in a statement. The country's border with the Democratic Republic of Congo (DRC) is southeast of the main outbreak area, and vaccination with VSV-EBOV began at the Gatumba entry point.
US Sen. Sherrod Brown, D-Ohio, yesterday reintroduced legislation to strengthen the federal government's response to antibiotic resistance.
Genomic analysis suggests C difficile strains that have spread in hospitals belong to an emerging species.
Earlier the summer, the CDC warned doctors to be alert for AFM cases that seem to rise late summer and fall alongside enterovirus activity.
Also, insecurity flares again in Beni, with suspected ADF attacks and resulting community protests.
A modeling study that incorporated air movement patterns from farms affected early in the highly pathogenic H5N2 avian influenza outbreak that hit US poultry in 2015 suggests that most affected farms in Iowa may have received airborne virus from farms within and outside the state.
The addition of a beta-lactam antibiotic to daptomycin is associated with improved clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bloodstream infections (MRSA BSIs), researchers reported yesterday in Clinical Infectious Diseases.
Officials hope the promising treatment findings encourage more patients to seek lifesaving treatment.
In US developments, the CDC confirms 10 more cases, and New York reports a new outbreak in a Mennonite community.
The Coalition for Epidemic Preparedness Innovations (CEPI) and Public Health Vaccines (PHV), LLC, have announced a partnership agreement worth up to $43.6 million to support the development and manufacturing of a Nipah virus vaccine.
In a statement today CEPI said it will fund preclinical studies, clinical studies through phase 2, manufacturing, and an investigational stockpile of the vaccine candidate.
Also, an expert warns the virus could become endemic, and researchers say an already approved drug might help.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A new study in BMC Medicine suggests a possible link between antibiotic use and the onset of rheumatoid arthritis (RA).
The National Institutes of Health (NIH) yesterday announced that researchers have started enrolling participants in a phase 1 clinical trial to evaluate immunogenicity and safety of two licensed seasonal flu vaccines given with and without novel adjuvants.
The report shows a substantial drop in the use of nearly all medically important antibiotics from 2013 to 2017.
Countries in the Americas have reported a 70% increase in the number of measles cases since mid June, according to an update yesterday from the Pan American Health Organization (PAHO).
A surveillance study of Italian hospitals found improved compliance with surgical antimicrobial prophylaxis (SAP) guidelines over a 6-year period, Italian researchers reported yesterday in the American Journal of Infection Control.
Four times as many children died from Ebola in the past 6 months compared with the previous 6 months.
